16S pan-bacterial PCR can accurately identify patients with ventilator-associated pneumonia

Thorax

Volumn 72, Issue 11, 2017, Pages 1046-1048

  Conway Morris, Andrew ^a,b   Gadsby, Naomi ^c   McKenna, James P ^d   Hellyer, Thomas P ^e   Dark, Paul ^f,g   Singh, Suveer ^h   Walsh, Timothy S ^b   McAuley, Danny F ^i,j   Templeton, Kate ^c   Simpson, A John ^e   McMullan, Ronan ^d,i  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NHS LOTHIAN   (United Kingdom)

^d ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^h CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

ⁱ QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^j ROYAL VICTORIA INFIRMARY   (United Kingdom)

more..

Author keywords

Assisted Ventilation; Bacterial Infection; Pneumonia

Indexed keywords

RNA 16S; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

16SRRNA GENE; ADULT; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HYBRIDIZATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VENTILATOR ASSOCIATED PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; INTENSIVE CARE UNIT; METABOLISM; MICROBIOLOGY; MULTICENTER STUDY; PREDICTIVE VALUE; UNITED KINGDOM; VALIDATION STUDY;

ANTI-BACTERIAL AGENTS; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; COHORT STUDIES; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; PREDICTIVE VALUE OF TESTS; RNA, RIBOSOMAL, 16S; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

EID: 85006998190     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-209065     Document Type: Article

References (12)

1. Hunter JD. Ventilator associated pneumonia. BMJ 2012;344:e3325.
2. Behnke M, Hansen S, Leistner R, et al. Nosocomial infection and antibiotic use: A second national prevalence study in Germany. Dtsch Arztebl Int 2013;110:627-33.
3. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
4. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
5. McGowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Clin Infect Dis 1983;5:1033-48.
6. Kett DH, Cano E, Quartin AA, et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: An observational, multicentre cohort study. Lancet Infect Dis 2011;11:181-9.
7. Renvoisé A, Brossier F, Sougakoff W, et al. Broad-range PCR: Past, present, or future of bacteriology?. Med Mal Infect 2013;43:322-30.
8. Conway Morris A, Kefala K, Wilkinson TS, et al. Diagnostic importance of pulmonary interleukin-1 beta and interleukin-8 in ventilator-associated pneumonia Thorax 2010;65:201-7.
9. Hellyer TP, Morris AC, McAuley DF, et al. Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia. Thorax 2015;70:41-7.
10. Schabereiter-Gurtner C, Nehr M, Apfalter P, et al. Evaluation of a protocol for molecular broad-range diagnosis of culture-negative bacterial infections in clinical routine diagnosis. J Appl Microbiol 2008;104:1228-37.
11. Yang S, Lin S, Kelen GD, et al. Quantitative multiprobe PCR assay for simultaneous detection and identification to species level of bacterial pathogens. J Clin Microbiol 2002;40:3449-54.
12. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 1993;147:38-44.